BioLight Medical Devices


Therapeutic Area(s):
Allergy, Ear Nose &Throat (ENT)
Company Status:
Initial Revenues

Company at a Glance

BioLight is the producer of electronic phototherapy devices, based on low level narrow band red light. Our devices offer non-invasive, drug-free, side-effect-free treatment for: hay fever, oral lesions, chronic pain and rheumatoid arthritis as well as acne and chronic wounds.
BioLight recently developed the new BioNette, a sophisticated second generation of the original BioNase that very effectively treats hay fever (allergy rhinitis).
Allergic rhinitis is a 21st century disease unknown before the 18th century. Researchers predict that within 20 years 50% of western population will suffer from it (today it is estimated that approx. 20%-25% of the population suffers from allergic rhinitis).
Due to the BioNette’s unique design and technology, it has already been chosen by some of the world’s largest retailers and distributors including:
Boots (UK), the largest health and beauty chain in the world, Sinopharm (China), the largest pharmaceutical conglomerate in China, Hanmi Medicare (Korea), the second largest pharmaceutical conglomerate in Korea, Wholesale Medical Network (WMNI, Canada), a very respected wholesaler in Canada Probiomed (Mexico), one of a largest Mexican wholesaler Marpel Pharma (Central America), a leading pharmaceutical distributor Gala Optics (Russia), a leading medical distributor Neurofharma (Colombia), Macrotel S.A. (Chile), Almed Group (Turkey), Interlux (Baltic)

Technology & Product(s)

BioLights’ other products are:
BioStick – a personal device for treating aphthas, gingivitis, cold sores etc.
BioBeam 660 – for treating acne and non-healing wounds
BioBeam 940 – for relieving rheumatic arthritis pains
The device is currently used in USA, France, Spain, Italy and Poland.

Goals

Objectives: BioLight is looking for reputable distributors and wholesalers to collaborate in the selling and marketing of the BioNette.
Target businesses: Medical devices distributors, wholesalers and investors.
Target Countries: Europe, Other territories.